192 related articles for article (PubMed ID: 12066201)
1. Morphologic approach to hepatocellular carcinoma development in man: de novo or the so-called 'dysplastic nodule-carcinoma' sequence?
Taguchi K; Asayama Y; Aishima S; Nishi H; Sugimachi K; Matsuura S; Terashi T; Yamanaka T; Shimada M; Sugimachi K; Tsuneyoshi M
Oncol Rep; 2002; 9(4):737-43. PubMed ID: 12066201
[TBL] [Abstract][Full Text] [Related]
2. Significance of the relationship between irregular regeneration and two hepatocarcinogenic pathways: "de novo" and so-called "dysplastic nodule-hepatocellular carcinoma" sequence.
Taguchi K; Aishima S; Matsuura S; Terashi T; Nishiyama K; Shirabe K; Shimada M; Maehara Y; Tsuneyoshi M
J Surg Oncol; 2005 Nov; 92(2):100-3. PubMed ID: 16231367
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas.
Maeda T; Takenaka K; Taguchi K; Kajiyama K; Shirabe K; Shimada M; Tsuneyoshi M; Sugimachi K
Hepatogastroenterology; 2000; 47(32):498-503. PubMed ID: 10791221
[TBL] [Abstract][Full Text] [Related]
4. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
[TBL] [Abstract][Full Text] [Related]
5. [Hepatic cell dysplasia. A pre-malignant lesion related to hepatocellular carcinoma and infection by hepatitis B virus].
de Queiroz AC; Moreira DE; Andrade ML
Arq Gastroenterol; 1987; 24(2):80-3. PubMed ID: 2849924
[TBL] [Abstract][Full Text] [Related]
6. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
7. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
Szczepański W
Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study.
Seki S; Sakaguchi H; Kitada T; Tamori A; Takeda T; Kawada N; Habu D; Nakatani K; Nishiguchi S; Shiomi S
Clin Cancer Res; 2000 Sep; 6(9):3469-73. PubMed ID: 10999730
[TBL] [Abstract][Full Text] [Related]
9. Morphological changes of early human hepatocarcinogenesis.
Hytiroglou P
Semin Liver Dis; 2004 Feb; 24(1):65-75. PubMed ID: 15085487
[TBL] [Abstract][Full Text] [Related]
10. The Sialyl Lewis X expression in hepatocarcinogenesis: potential predictor for the emergence of hepatocellular carcinoma.
Fujiwara Y; Shimada M; Takenaka K; Kajiyama K; Shirabe K; Sugimachi K
Hepatogastroenterology; 2002; 49(43):213-7. PubMed ID: 11941958
[TBL] [Abstract][Full Text] [Related]
11. Liver cell dysplasia in alpha-1-antitrypsin deficiency.
Cohen C; Derose PB
Mod Pathol; 1994 Jan; 7(1):31-6. PubMed ID: 8159650
[TBL] [Abstract][Full Text] [Related]
12. Liver-cell dysplasia and hepatocellular carcinoma.
Podda M; Roncalli M; Battezzati PM; Borzio M; Bruno S; Servida E; Coggi G
Ital J Gastroenterol; 1992 Jan; 24(1):39-42. PubMed ID: 1315175
[TBL] [Abstract][Full Text] [Related]
13. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
14. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
[TBL] [Abstract][Full Text] [Related]
15. [Hepatocellular nodular hyperplasias, adenomas and carcinomas].
Altmann HW
Verh Dtsch Ges Pathol; 1995; 79():84-108. PubMed ID: 8600698
[TBL] [Abstract][Full Text] [Related]
16. [Premalignant lesions and hepatocellular carcinoma on non cirrhotic liver overloaded with iron].
Attia A; Blanc JF; Saric J; Balabaud C; Bioulac-Sage P
Gastroenterol Clin Biol; 2000 Oct; 24(10):955-9. PubMed ID: 11084432
[TBL] [Abstract][Full Text] [Related]
17. Multifocal hepatocellular carcinoma and precancerous lesions in a patient with autoimmune hepatitis-related cirrhosis.
Ward SC; Deniz K; Roayaie S; Qin L
Semin Liver Dis; 2008 Feb; 28(1):123-7. PubMed ID: 18293282
[TBL] [Abstract][Full Text] [Related]
18. Sister chromatid exchange and mitotic index in patients with cirrhosis related to hepatitis B and C viruses and in chronic carriers.
Ucur A; Palanduz S; Cefle K; Ozturk S; Tutkan G; Vatansever S; Erden S; Karan MA; Erten N; Guler K; Tascioglu C
Hepatogastroenterology; 2003; 50(54):2137-40. PubMed ID: 14696481
[TBL] [Abstract][Full Text] [Related]
19. Hepatic precancerous lesions and small hepatocellular carcinoma.
Hytiroglou P; Park YN; Krinsky G; Theise ND
Gastroenterol Clin North Am; 2007 Dec; 36(4):867-87, vii. PubMed ID: 17996795
[TBL] [Abstract][Full Text] [Related]
20. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
